U.S. Markets close in 3 hrs 3 mins

GoodRx Holdings, Inc. (GDRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
42.47-0.02 (-0.05%)
As of 12:57PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close42.49
Open42.70
Bid42.46 x 800
Ask42.53 x 800
Day's Range41.31 - 43.30
52 Week Range33.51 - 64.22
Volume581,593
Avg. Volume2,845,590
Market Cap16.621B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateNov 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est48.69
  • Lawsuits Filed Against SPLK, NAK and GDRX - Jakubowitz Law Pursues Shareholders Claims
    ACCESSWIRE

    Lawsuits Filed Against SPLK, NAK and GDRX - Jakubowitz Law Pursues Shareholders Claims

    NEW YORK, NY / ACCESSWIRE / January 20, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court.

  • GlobeNewswire

    Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against GoodRx Holdings, Inc. – GDRX

    NEW YORK, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020 and November 16, 2020, inclusive (the “Class Period”). To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=goodrx-holdings-inc&id=2531 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action. 如果您想加入这个集体诉讼案,请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=goodrx-holdings-inc&id=2531 If you wish to serve as lead plaintiff, you must move the Court before the February 16, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that- Amazon.com, Inc. was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. According to the GoodRx class action lawsuit, given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, their statements in the Registration Statement and during the Class Period about GoodRx’s competitive position were materially false and/or misleading when made and caused GoodRx Class A common stock to trade at artificially inflated prices of more than $64 per share during the Class Period. Lead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time. Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes. Zhang Investor Law P.C.99 Wall Street, Suite 232New York, New York 10005info@zhanginvestorlaw.comtel: (800) 991-3756

  • LAWSUITS FILED AGAINST PEN, GDRX and OTGLY - Jakubowitz Law Pursues Shareholders Claims
    ACCESSWIRE

    LAWSUITS FILED AGAINST PEN, GDRX and OTGLY - Jakubowitz Law Pursues Shareholders Claims

    NEW YORK, NY / ACCESSWIRE / January 19, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court.